Hilary S. Gammill
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hilary S. Gammill has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Jacob O. Kitzman
2 shared publications- Jay Shendure
Department of Genome Sciences, University of Washington, Seattle, WA, USA
2 shared publications LaVone E. Simmons
2 shared publicationsMatthew W. Snyder
From the Department of Genome Sciences (M.W.S., J.O.K., B.P.C., R.M.D., E.E.E., J.S.), Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology (L.E.S., J.M.H., H.S.G.), and Howard Hughes Medical Institute (E.E.E.), University of Washington, and the Clinical Research Division, Fred Hutchinson Cancer Research Center (H.S.G.) - both in Seattle
2 shared publicationsAlina N. Brewer
1 shared publicationBradley P. Coe
1 shared publication
Latest Publications
- 23 April 2015
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 372 (17) , 1639-1645
Copy-Number Variation and False Positive Prenatal Aneuploidy Screening Results
Investigations of noninvasive prenatal screening for aneuploidy by analysis of circulating cell-free DNA (cfDNA) have shown high sensitivity and specificity in both high-risk and low-risk cohorts. However, the overall low incidence of aneuploidy limits the positive predictive value of these tests. Currently, the causes of false positive results are poorly understood. We investigated four pregnancies with discordant prenatal test results and found in two cases that maternal duplications on chromosome 18 were the likely cause of the discordant results. Modeling based on population-level copy-number variation supports the possibility that some false positive results of noninvasive prenatal screening may be attributable to large maternal copy-number variants. (Funded by the National Institutes of Health and others.)
- 23 April 2015
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 372 (17) , 1639-1645
Copy-Number Variation and False Positive Prenatal Aneuploidy Screening Results
Investigations of noninvasive prenatal screening for aneuploidy by analysis of circulating cell-free DNA (cfDNA) have shown high sensitivity and specificity in both high-risk and low-risk cohorts. However, the overall low incidence of aneuploidy limits the positive predictive value of these tests. Currently, the causes of false positive results are poorly understood. We investigated four pregnancies with discordant prenatal test results and found in two cases that maternal duplications on chromosome 18 were the likely cause of the discordant results. Modeling based on population-level copy-number variation supports the possibility that some false positive results of noninvasive prenatal screening may be attributable to large maternal copy-number variants. (Funded by the National Institutes of Health and others.)
- Open Access
- 1 April 2013
- Published by Wiley in Prenatal Diagnosis
- Vol. 33 (6) , 547-554
Noninvasive fetal genome sequencing: a primer
We recently demonstrated whole genome sequencing of a human fetus using only parental DNA samples and plasma from the pregnant mother. This proof‐of‐concept study demonstrated how samples obtained noninvasively in the first or second trimester can be analyzed to yield a highly accurate and substantially complete genetic profile of the fetus, including both inherited and de novo variation. Here, we revisit our original study from a clinical standpoint, provide an overview of the scientific approach, and describe opportunities and challenges along the path toward clinical adoption of noninvasive fetal whole genome sequencing. © 2013 John Wiley & Sons, Ltd.
- 1 April 2013
- Published by Wiley in Prenatal Diagnosis
- Vol. 33 (6) , 547-554
Open AccessNoninvasive fetal genome sequencing: a primer
We recently demonstrated whole genome sequencing of a human fetus using only parental DNA samples and plasma from the pregnant mother. This proof‐of‐concept study demonstrated how samples obtained noninvasively in the first or second trimester can be analyzed to yield a highly accurate and substantially complete genetic profile of the fetus, including both inherited and de novo variation. Here, we revisit our original study from a clinical standpoint, provide an overview of the scientific approach, and describe opportunities and challenges along the path toward clinical adoption of noninvasive fetal whole genome sequencing. © 2013 John Wiley & Sons, Ltd.